Envestnet Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200M | Sell |
|
|||||
|
2025
Q1 | $228M | Buy |
|
|||||
|
2024
Q4 | $170M | Buy |
|
|||||
|
2024
Q3 | $187M | Sell |
|
|||||
|
2024
Q2 | $195M | Buy |
|
|||||
|
2024
Q1 | $169M | Sell |
|
|||||
|
2023
Q4 | $168M | Buy |
|
|||||
|
2023
Q3 | $143M | Buy |
|
|||||
|
2023
Q2 | $108M | Sell |
|
|||||
|
2023
Q1 | $92.7M | Buy |
|
|||||
|
2022
Q4 | $82.1M | Buy |
|
|||||
|
2022
Q3 | $78M | Buy |
|
|||||
|
2022
Q2 | $72M | Sell |
|
|||||
|
2022
Q1 | $80.3M | Buy |
|
|||||
|
2021
Q4 | $59.1M | Buy |
|
|||||
|
2021
Q3 | $45.1M | Buy |
|
|||||
|
2021
Q2 | $39.3M | Sell |
|
|||||
|
2021
Q1 | $44.8M | Buy |
|
|||||
|
2020
Q4 | $44.7M | Sell |
|
|||||
|
2020
Q3 | $51.4M | Buy |
|
|||||
|
2020
Q2 | $47.4M | Buy |
|
|||||
|
2020
Q1 | $27.2M | Buy |
|
|||||
|
2019
Q4 | $20.6M | Buy |
|
|||||
|
2019
Q3 | $14.8M | Buy |
|
|||||
|
2019
Q2 | $15.4M | Buy |
|
|||||
|
2019
Q1 | $14.8M | Buy |
|
|||||
|
2018
Q4 | $11.9M | Buy |
|
|||||
|
2018
Q3 | $2.45M | Sell |
|
|||||
|
2018
Q2 | $4.51M | Buy |
|
|||||
|
2018
Q1 | $2.88M | Sell |
|
|||||
|
2017
Q4 | $5.04M | Buy |
|
|||||
|
2017
Q3 | $4.9M | Buy |
|
|||||
|
2017
Q2 | $3.11M | Buy |
|
|||||
|
2017
Q1 | $2.04M | Buy |
|
|||||
|
2016
Q4 | $1.11M | Sell |
|
|||||
|
2016
Q3 | $1.54M | Sell |
|
|||||
|
2016
Q2 | $2.32M | Sell |
|
|||||
|
2016
Q1 | $2.31M | Sell |
|
|||||
|
2015
Q4 | $3.91M | Sell |
|
|||||
|
2015
Q3 | $3.61M | Buy |
|
|||||
|
2015
Q2 | $3.97M | Buy |
|
|||||
|
2015
Q1 | $3.57M | Buy |
|
|||||
|
2014
Q4 | $23K | Buy |
|
|||||
|
2014
Q3 | $20K | Buy |
|
|||||
|
2014
Q2 | $9K | Sell |
|
|||||
|
2014
Q1 | $11K | Sell |
|
|||||
|
2013
Q4 | $15K | Sell |
|
|||||
|
2013
Q3 | $46K | Buy |
|
|||||
|
2013
Q2 | $48K | Buy |
|